A New Option for Some People With Lung Cancer: What the Approval of Lorlatinib Means for Patients

A New Option for Some People With Lung Cancer: What the Approval of Lorlatinib Means for Patients

The FDA recently approved the drug lorlatinib for the treatment of some non-small cell lung cancer. Doctors talk to SurvivorNet about the significance of this approval.

NOW
PLAYING
A New Option for Some People With Lung Cancer: How This Immunotherapy/Chemotherapy Combo Can Increase Treatment Success
NOW
PLAYING
Legendary Singer Nat King Cole Passed from Lung Cancer at 45; What to Know About this Disease
NOW
PLAYING
Some Hand Sanitizers Found to Contain Cancer-Causing Compound Benzene; How Cancer Patients Can Protect Themselves During COVID-19
NOW
PLAYING
Can Metastatic Bladder Cancer Be Treated With Immunotherapy?
NOW
PLAYING
Remembering 80s Actor Paul Gleason, From Trading Places & The Breakfast Club, Who Died of Mesothelioma -- Some New Treatments Finally Available
NOW
PLAYING
Black Americans Don't Get Screened or Treated for Lung Cancer at the Same Rates as White Americans: Here's Why, and What We Can Do About It

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.